SCHEMBL1865474

SCHEMBL1865474

CC(C)(C)[C@@H](NC(=O)O)C1CCN(C2COC2)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 1/20 0.32
SIGMAR1 Q99720 1/20 0.30
KDM2B Q8NHM5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1700425 1.00 CCR8 (0.32) CCR8SIGMAR1KDM2B
SCHEMBL1863283 0.88 ALDH1A1 (0.35) SIGMAR1KDM2B
SCHEMBL1867290 0.88 ALDH1A1 (0.35) SIGMAR1KDM2B
SCHEMBL1700192 0.88 ALDH1A1 (0.35) SIGMAR1KDM2B
SCHEMBL1958107 0.79
SCHEMBL1700055 0.74 EPHX2 (0.36)
SCHEMBL1700046 0.72 TSHR (0.43)
SCHEMBL2276120 0.70 TP53 (0.34)
SCHEMBL1700073 0.69 EPHX2 (0.35) SIGMAR1
SCHEMBL23337914 0.69 MAP3K12 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138588-A9 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-05-05 WO disclosed